In one aspect, the invention relates to compounds, including phenylethynylbenzamide derivatives, cycloalkylethynylbenzamide derivatives, styrylbenzamide derivatives, 4-(3-phenyl-1,2,4-oxadiazol-5-yl)benzamide derivatives, 4-(pyridinylethynyl)benzamide derivatives, and N
1
-phenylterephthalamide derivatives, which are useful as positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
本发明涉及化合物,包括
苯乙炔基
苯甲
酰胺衍
生物、
环烷基
乙炔基
苯甲
酰胺衍
生物、
苯乙烯基
苯甲
酰胺衍
生物、4-(3-
苯基-1,
2,4-
噁唑-5-基)
苯甲
酰胺衍
生物、4-(
吡啶乙炔基)
苯甲
酰胺衍
生物和N1-
苯基对
苯二甲
酰胺衍
生物,它们是代谢型谷
氨酸受体亚型5 (mGluR5) 的正向变构调节剂;制备这些化合物的合成方法;含有这些化合物的药物组合物;以及使用这些化合物和组合物治疗与谷
氨酸功能失调相关的神经和精神障碍的方法。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明。